ReviewPharmacological research2026
Mitochondrial vulnerability to aldehydic load and the role mitochondrial aldehyde dehydrogenases.
Review in Pharmacological research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Mitochondria are the metabolic hubs of the cell; they are major sites of ATP production through cellular respiration and the electron transfer chain, and thus generators of certain amounts of reactive oxygen species (ROS); they participate in the production of most of the cell building blocks, including nucleotides and amino acids; they produce many hormones and neurotransmitters; and they have extensive metabolic reactions, including carbohydrate and lipids metabolism. All these mitochondrial activities contribute to accumulation of toxic and reactive aldehydes that can react with all macromolecules. Accumulated aldehydes covalently bind to proteins, DNA, and lipids, damaging these macromolecules and thus the mitochondrial functions. It is therefore not surprising that mitochondrial dysfunction is associated with many acute and chronic human diseases. In addition to endogenous biogenic aldehydes, exogenous aldehydes, such as those from air pollution, highly processed or fried food, can contribute to mitochondrial dysfunctions through increased mitochondrial aldehydic load. Here we discuss some of the built-in mechanisms in mitochondria that help detoxify aldehydes; these are members of a larger family of aldehyde dehydrogenases (ALDHs) that provide some defense from aldehydic load. Aldehydic burden on the mitochondria can also be reduced through simple lifestyle changes. Although such changes alone are insufficient, increasing public health awareness may provide a path for a more effective action to reduce the contribution of mitochondrial dysfunction to human pathologies. (228/250 words).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.